Myriad Genetics Inc
SWB:MYD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Myriad Genetics Inc
SWB:MYD
|
US |
|
Southwest Gas Holdings Inc
F:SZR
|
US |
|
K
|
Krystal Biotech Inc
F:4KB
|
US |
|
M
|
Murphy Usa Inc
XBER:1MU
|
US |
|
T
|
Takeda Pharmaceutical Co Ltd
OTC:TKPHF
|
JP |
|
T
|
Telefonaktiebolaget LM Ericsson
F:ERCB
|
SE |
Wall St Price Targets
MYD Price Targets Summary
Myriad Genetics Inc
According to Wall Street analysts, the average 1-year price target for
MYD is 6.373 EUR with a low forecast of 2.988 EUR and a high forecast of 15.976 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MYD's stock price target?
Price Target
6.373
EUR
According to Wall Street analysts, the average 1-year price target for
MYD is 6.373 EUR with a low forecast of 2.988 EUR and a high forecast of 15.976 EUR.
What is the Revenue forecast for Myriad Genetics Inc?
Projected CAGR
6%
Over the last 4 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 5 years is 6%.